Christy Toms

1.5k total citations
16 papers, 922 citations indexed

About

Christy Toms is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Christy Toms has authored 16 papers receiving a total of 922 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Christy Toms's work include DNA Repair Mechanisms (4 papers), BRCA gene mutations in cancer (4 papers) and PARP inhibition in cancer therapy (4 papers). Christy Toms is often cited by papers focused on DNA Repair Mechanisms (4 papers), BRCA gene mutations in cancer (4 papers) and PARP inhibition in cancer therapy (4 papers). Christy Toms collaborates with scholars based in United Kingdom, Spain and United States. Christy Toms's co-authors include Fiona Powrie, Lorena Maestre, Khoon‐Lin Ling, Bridget C. Fox, Philip J. Brown, Jorge L. Martínez‐Torrecuadrada, Vincenzo Cerundolo, Sarah Pratap, Sophie Hüe and Giovanna Roncador and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Oncogene.

In The Last Decade

Christy Toms

15 papers receiving 899 citations

Peers

Countries citing papers authored by Christy Toms

Since Specialization

Citations

This map shows the geographic impact of Christy Toms's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christy Toms with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christy Toms more than expected).

Fields of papers citing papers by Christy Toms

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christy Toms. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christy Toms. The network helps show where Christy Toms may publish in the future.

Co-authorship network of co-authors of Christy Toms

This figure shows the co-authorship network connecting the top 25 collaborators of Christy Toms. A scholar is included among the top collaborators of Christy Toms based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christy Toms. Christy Toms is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	HALT: targeted therapy with or without dose-intensified radiotherapy in oligo-progressive disease in oncogene addicted lung tumours 2021 ·Lung Cancer ·Fiona McDonald, Matthias Gückenberger, Sanjay Popat, Corinne Faivre‐Finn, Nicolaus Andratschke, Angela M. Riddell, Gerard G. Hanna, Vineet Prakash, Arjun Nair, Patricia Díez, Priyanka Patel, Lucy Kilburn, Christy Toms, Judith M. Bliss	0
2	1O Detection of homologous recombination repair deficiency (HRD) in treatment-naive early triple-negative breast cancer (TNBC) by RAD51 foci and comparison with DNA-based tests 2021 ·Annals of Oncology ·(unknown), Alba Llop‐Guevara, Alex Pearson, Cristina Cruz, Marta Castroviejo‐Bermejo, Neha Chopra, Holly Tovey, Christy Toms, Divya Kriplani, Heidrun Gevensleben, Rebecca Roylance, Stephen Chan, Andrew Tutt, A. Skene, Abigail Evans, Helen Davies, Judith M. Bliss, Serena Nik‐Zainal, Judith Balmañà, Nicholas C. Turner	4
3	ATARI trial: ATR inhibitor in combination with olaparib in gynecological cancers with ARID1A loss or no loss (ENGOT/GYN1/NCRI) 2021 ·International Journal of Gynecological Cancer ·Susana Banerjee, James Stewart, Núria Porta, Christy Toms, Alexandra Léary, Stéphanie Lheureux, Saira Khalique, (unknown), Ayoma D. Attygalle, Katherine Vroobel, Christopher J. Lord, Rachael Natrajan, Judith M. Bliss	41
4	Assessment of structural chromosomal instability phenotypes as biomarkers of carboplatin response in triple negative breast cancer: the TNT trial 2020 ·Annals of Oncology ·(unknown), Holly Tovey, Jelmar Quist, Syed Haider, (unknown), Patrycja Gazińska, Sarah Kernaghan, Christy Toms, Sarah Maguire, Nick Orr, Sabine C. Linn, Julie Owen, Cheryl Gillett, Sarah E. Pinder, Judith M. Bliss, Andrew Tutt, Maggie C.U. Cheang, Anita Grigoriadis	17
5	Abstract P1-06-07: Characterization of chromosomal instability in the TNT trial: A randomized phase III trial of carboplatin compared with docetaxel for patients with metastatic or recurrent locally advanced triple negative or BRCA1/2 breast cancer (CRUK/07/012) 2019 ·Cancer Research ·(unknown), Holly Tovey, Jelmar Quist, Syed Mahmood Haider, (unknown), Patrycja Gazińska, Sarah Kernaghan, Christy Toms, (unknown), J. S. Lanchbury, SC Linn, S Pinder, Judith M. Bliss, Andrew Tutt, Maggie C.U. Cheang, Anita Grigoriadis, (unknown)	1
6	Activity of cediranib in alveolar soft part sarcoma (ASPS) confirmed by CASPS (cediranib in ASPS), an international, randomised phase II trial (C2130/A12118). 2017 ·Journal of Clinical Oncology ·Ian Judson, James P. Morden, Michael Leahy, Vivek A. Bhadri, Quentin Campbell‐Hewson, Ricardo Cubedo, Adam Dangoor, I. Hennig, Warren Joubert, Sarah Kernaghan, Antonio López–Pousa, Beatrice Seddon, Claire Snowdon, (unknown), Christy Toms, Javier Martínez‐Trufero, Judith M. Bliss, (unknown)	13
7	Window study of the PARP inhibitor rucaparib in patients with primary triple negative or BRCA1/2 related breast cancer (RIO) 2016 ·Annals of Oncology ·Christy Toms, Neha Chopra, (unknown), (unknown), Lucy Kilburn, Judith M. Bliss, Nicholas C. Turner	8
8	Medical student perception of anatomage – A 3D interactive anatomy dissection table 2015 ·International Journal of Surgery ·(unknown), (unknown), (unknown), (unknown), Christy Toms, (unknown), J. Wilton	16
9	Managing non-proportionality of hazards (PH) within TNT: a randomised phase III trial of carboplatin compared to docetaxel for patients with metastatic or recurrent locally advanced triple negative (TN) or brca1/2 breast cancer (BC) 2015 ·Trials ·(unknown), Holly Tovey, Judith M. Bliss, Andrew Tutt, James P. Morden, (unknown), Sue Martin, Sarah Kernaghan, Christy Toms, Lucy Kilburn	4
10	Self-management support using an Internet-linked tablet computer (the EDGE platform)-based intervention in chronic obstructive pulmonary disease: protocol for the EDGE-COPD randomised controlled trial 2014 ·BMJ Open ·Andrew Farmer, Christy Toms, Maxine Hardinge, Veronika Williams, Heather Rutter, Lionel Tarassenko	27
11	Corticosteroid injection for shoulder pain: single-blind randomized pilot trial in primary care 2013 ·Trials ·Tim Holt, David Mant, Andrew Carr, Stephen Gwilym, David Beard, Christy Toms, Ly‐Mee Yu, Jonathan Rees	19
12	Gpr83 expression is not required for the maintenance of intestinal immune homeostasis and regulation of T‐cell‐dependent colitis 2008 ·Immunology ·Christy Toms, Heidi K. Jessup, Claire Hartmann‐Thompson, Dilair Baban, Kay E. Davies, Fiona Powrie	10
13	Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level 2005 ·European Journal of Immunology ·Giovanna Roncador, Philip J. Brown, Lorena Maestre, Sophie Hüe, Jorge L. Martínez‐Torrecuadrada, Khoon‐Lin Ling, Sarah Pratap, Christy Toms, Bridget C. Fox, Vincenzo Cerundolo, Fiona Powrie, Alison H. Banham	495
14	Control of intestinal inflammation by regulatory T cells 2001 ·Microbes and Infection ·Christy Toms, Fiona Powrie	69
15	Pharmacological differences between the human and rat vanilloid receptor 1 (VR1) 2001 ·British Journal of Pharmacology ·Peter McIntyre, Linda M. McLatchie, Anne Chambers, Elsa Phillips, Melanie Clarke, Jonathan R. Savidge, Christy Toms, Marcus Peacock, Kirti Shah, Janet Winter, (unknown), (unknown), H P Rang, Stuart Bevan, Iain F. James	166
16	Characterization of the mouse Ron/Stk receptor tyrosine kinase gene 1998 ·Oncogene ·Susan E. Waltz, Christy Toms, Susan A. McDowell, (unknown), Rebecca S. Muraoka, Ellen L. Air, William Sun, Mary Beth Thomas, Sandra J. Friezner Degen	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact